Autoimmune Disease Diagnostics Market (By Disease Segment, Test Types, Country Analysis), Company Profiles, Financial Insights, Strategy and Recent Developments - Global Forecast to 2030

Apelo Consulting has released a report on Autoimmune Disease Diagnostics Market (By Disease Segment, Test Types, Country Analysis), Company Profiles, Financial Insights, Strategy and Recent Developments - Global Forecast to 2030.

The global autoimmune disease diagnostics market was valued at USD 6,583 Million in 2024, and the market is projected to reach USD 10,423 Million by 2030. Autoimmune diseases are characterized by an abnormal immune response in which the body produces antibodies that mistakenly attack its own cells and tissues, leading to the deterioration and destruction of healthy tissue. There are more than 80 known types of autoimmune diseases worldwide, including well-known conditions such as systemic lupus erythematosus (SLE) and rheumatoid arthritis. Autoimmune diseases can be divided into two general groups: Organ specific, where the autoantibodies attack a specific organ, and Non-organ specific (or systemic), where the autoantibodies attack multiple organ systems. For example, in Hashimoto’s thyroiditis, autoantibodies specifically target and damage the thyroid gland. In contrast, systemic autoimmune diseases involve multiple organ systems. A classic example is systemic lupus erythematosus (SLE), in which autoantibodies can affect a wide range of tissues and organs throughout the body.

The increasing incidence of conditions like rheumatoid arthritis and Hashimoto’s thyroiditis, coupled with supportive government policies, is expected to significantly influence the growth of the autoimmune disease diagnostics market. According to the American Autoimmune Related Diseases Association, more than 50 million people in the United States are currently affected by autoimmune disorders. This number is projected to rise in the coming years. Consequently, the growing need for accurate and advanced diagnostic techniques, alongside the rising prevalence of these diseases, is anticipated to propel market expansion over the forecast period.

For more details: https://apeloconsulting.com/product/autoimmune-disease-diagnostics-market-by-disease-segment-test-types-country-analysis-company-profiles-financial-insights-strategy-and-recent-developments-global-forecast-to-2030/

Transcript

1. Autoimmune Disease Diagnostics Market 2024-2030 A comprehensive analysis of market size, growth projections, segmentation, regional trends, and key industry players in the global autoimmune diagnostics landscape September 2025 Apelo Consulting
2. Market Overview & Size Key Market Metrics Market valued at USD 6,583 Million in 2024 Projected to reach USD 10,423 Million by 2030 Robust 7.9% CAGR during the forecast period Growth driven by increasing prevalence of autoimmune conditions and technological advancements Market Growth Projection (2024-2030) Apelo Consulting Page 2
3. Understanding Autoimmune Diseases 80+ known types of autoimmune diseases worldwide Abnormal immune response where the body's immune system attacks its own cells and tissues Results in deterioration and destruction of healthy tissue Common examples: Hashimoto's thyroiditis (organ- specific) and Systemic Lupus Erythematosus (systemic) Two Major Categories Organ-Specific Apelo Consulting Page 3 Autoantibodies target a specific organ Example: Hashimoto's thyroiditis attacks thyroid gland Type 1 diabetes, Multiple sclerosis Systemic Autoantibodies attack multiple organ systems Example: SLE affects tissues throughout body Rheumatoid arthritis, Ankylosing spondylitis
4. Market Drivers Key Growth Factors 50+ million Americans currently affected by autoimmune disorders Risingglobal prevalence across Asia-Pacific, Europe, and developing regions Supportive government policies and increased healthcare funding Growing demand for advanced diagnostic techniques with higher accuracy Global Autoimmune Disease Prevalence Trend Apelo Consulting Page 4
5. Recent Market Developments Key Innovations Recent breakthroughs in autoimmune diagnostic technologies are transforming patient care and market landscape These innovations represent significant advancements in precision medicine for autoimmune disease management Predicta Biosciences Launched its first molecular diagnostic product to optimize the prognosis of multiple myeloma, bringing advanced precision oncology to autoimmune diagnostics FEBRUARY 2025 Biocon Biologics Launched YESINTEK (ustekinumab-kfce), a biosimilar option to Stelara in the US market for Crohn's disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis DECEMBER 2024 Quest Diagnostics Introduced a revolutionary autoimmune disease diagnostic service using AI algorithms to analyze test results in real time, providing clinicians with instant feedback on patient status Page 5 Apelo Consulting APRIL 2025
6. Disease Segmentation Types of Autoimmune Diseases Autoimmune diseases are categorized into two general groups based on their impact on the body: Organ-specific: Autoantibodies target a specific organ Systemic: Autoantibodies attack multiple organ systems Localized Autoimmune Diseases Multiple Sclerosis Highest market share in localized segment (2024) Type 1 Diabetes Affects pancreatic islet cells Hashimoto's Thyroiditis Targets the thyroid gland Inflammatory Bowel Disease Affects the digestive tract Systemic Autoimmune Diseases Rheumatoid Arthritis Over 50% of systemic market share (2024) Systemic Lupus Erythematosus Affects multiple body systems Systemic Sclerosis Causes skin and tissue hardening Ankylosing Spondylitis Primarily affects the spine Localized vs Systemic Market Share Multiple Sclerosis (Highest Share) ApeloConsulting Page 6 Rheumatoid Arthritis (>50%)
7. Test Types Analysis Key Diagnostic Methods Autoantibody Tests: Captured largest market share in 2024; used for diagnosing various autoimmune disorders Antinuclear Antibody (ANA) Tests: Critical for diagnosing SLE, rheumatoid arthritis in primary care and specialty settings Complete Blood Count (CBC): Essential for diagnosing SLE, Idiopathic Thrombocytopenic Purpura, and Multiple Sclerosis Other Key Tests: ESR, CRP, Urinalysis, and Comprehensive Metabolic Panel Tests for comprehensive diagnosis Autoimmune Diagnostic Test Types Market Share (2024) Apelo Consulting Page 7
8. Regional Market Analysis Key Regional Insights North America: Largest market share, driven by high prevalence rates and advanced healthcare infrastructure Europe: Second-largest market, with multiple sclerosis prevalence at 83 per 100,000 population Asia-Pacific: Fastest-growing region, driven by large population, increasing disease prevalence, and healthcare investments South America & Middle East/Africa: Emerging markets with significant growth potential Regional Market Share Distribution (2024) Apelo Consulting Page 8
9. Key Market Players Leading Diagnostics Companies Abbott Laboratories Siemens Healthineers Roche Diagnostics bioMerieux SA EUROIMMUN AG Bio-Rad Laboratories Quest Diagnostics Thermo Fischer Scientific Inc. Danaher Corporation Market Positioning Matrix Apelo Consulting Page 9
10. Market Forecast & Conclusion Market Expected to Reach USD 10,423 Million by 2030 Strong Growth Drivers Rising prevalence of autoimmune conditions worldwide Technological innovation in diagnostic techniques Supportive government policies and healthcare investments Expanding awareness and early disease detection initiatives Stakeholder Opportunities Investment in AI-powered diagnostic tools Expansion into emerging markets in Asia-Pacific region Strategic partnerships for comprehensive diagnostic solutions Development of point-of-care testing solutions Market Growth Trend (2024-2030) Page 10 Apelo Consulting